Hematology Frontier Archives - Page 78 of 87

Dr. Zhang Huilai: Groundbreaking Research in Hodgkin Lymphoma

By Ran Zhang 2024.02.27

The 28th European Hematology Association (EHA) Congress took place from June 8 to 11, 2023, in Frankfurt, Germany, organized by the European Hematology Society. As one of the largest international…

Dr. Zhou Daobin: Exploring the Application of Sequential High-Dose Methotrexate in Newly Diagnosed Primary Central Nervous System Lymphoma Patients Without Chemotherapy

By Ran Zhang 2024.02.27

Editor's Note: Primary central nervous system lymphoma (PCNSL) is a relatively rare malignant tumor of the central nervous system, belonging to extranodal non-Hodgkin lymphoma. Due to factors such as the…

Chinese scientist awarded for groundbreaking work in transplantation, cellular therapy

By Lisa Cui 2024.02.25

Huang Xiaojun speaks with a patient at Peking University People's Hospital in Beijing, capital of China, July 6, 2023. (Xinhua/Zhang Yuwei) SAN ANTONIO, the United States, Feb. 24 (Xinhua) --…

The Future of Hematology: Expert Insights from EHA Conference

By Mourabit Halima 2024.02.23

Discover the latest advancements in hematology with our video series covering the European Hematology Association conference. This series offers a comprehensive analysis of pivotal studies such as the A031501/AMBASSADOR trial,…

Universal Anti-CD7 CAR-T Cells Targeting T-ALL: Functional Analysis and Potential Applications

By Yin, Jiale 2024.02.23

In December 2023, Professor Jianxiang Wang , the Chief Clinical Expert at the Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences , and his team, published a paper in Human…

Quizartinib Plus Chemotherapy in Newly Diagnosed Patients with FLT3-internal-tandem-duplication-positive Acute Myeloid Leukemia: A Phase 3 Trial

By Yin, Jiale 2024.02.23

In May 2023, Professor Jianxiang Wang , the Chief Clinical Expert at the Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, and his team, published a paper in The Lancet titled…

Current status of diagnosis and treatment of chronic lymphocytic leukemia in China: A nationalmulticenter survey research

By Yin, Jiale 2024.02.23

Professor Jun Ma and his team from Harbin Institute of Hematology Oncology published in May 2023 in the Chinese Journal of Hematology titled "Current status of diagnosis and treatment of chronic lymphocytic leukemia in…

Efficacy and safety of mitoxantrone hydrochloride liposome injection in treatment of peripheral T-celllymphomas: a multicenter, non-interventional, ambispective cohort, real-world study (MOMENT)

By Yin, Jiale 2024.02.23

In August 2023, Professor Jun Ma and his team from Harbin Institute of Hematology Oncology published a paper in the Journal of Leukemia & Lymphoma titled "Efficacy and safety of mitoxantrone hydrochloride…

Shanghai Institute of Hematology’s Team Led by Academician SaijuanChenand Chief Physician Jianqing Mi Unveils Temporal Characteristics of Cytokine Release and Molecular Mechanisms of CAR-T Re-expansion in Cell Immunotherapy

By Lisa Cui 2024.02.23

In January 2024, the team led by Academician Saijuan Chen and Chief Physician Jianqing Mi at the Shanghai Institute of Hematology published a research paper in the journal "Nature Communications." The…

Hematologica | Team Led by Jianxiang Wang Publishes Results of the Largest Domestic Prospective Cohort Study on Treating Adult Ph-negative ALL with Pediatric-inspired Regimen

By Lisa Cui 2024.02.23

Acute Lymphoblastic Leukemia (ALL) is a malignant hematologic tumor characterized by the clonal proliferation of immature lymphocytes in the bone marrow, peripheral blood, and extramedullary tissues. ALL predominantly affects children…